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Introduction
Pulmonary arterial stenosis is a relatively common complication 
after corrective surgery for congenital heart disease.
1-3) Branch pul-
monary arterial stenosis develops at a high rate after the repair of 
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Background and Objectives: Pulmonary arterial stenosis is a relatively common complication after corrective operation of congenital 
heart disease. Unilateral stenosis of pulmonary arteries could result in decrease perfusion of affected lung, pulmonary regurgitation, or 
elevation of right ventricular pressure. Eventually there are increasing risks of right ventricular failure, arrhythmia, or sudden death. How-
ever we have limited data of pulmonary arterial stent in paediatric population as the treatment of branch pulmonary stenosis. This study 
aimed at validating the effectiveness and investigating complications of pulmonary arterial stent implantation in a single institution dur-
ing mid-term follow up period. 
Subjects and Methods: A total of 42 patients (50 stents) were implanted for treating branch pulmonary arterial stenosis. We used car-
diac catheterization for comparing diameter after stent implantation directly and lung perfusion scan indirectly. We also investigated any 
adverse effect relating the procedure.
Results: Percent stenosis of stenotic lesions were decreased from 54.1±10.7% to 22.8±12.5% (p<0.001) and degree of decrement in af-
fected lung perfusion was declined from 22.7±8.0% to 10.3±9.0% (p<0.001) immediately and lasts during mid-term follow up period. 
Complication rate relating the procedure was 12% (6 out of 12) and there was no mortality case. 
Conclusion: This series showed immediate and short term effectiveness of pulmonary arterial stent in congenital heart defects. We con-
cluded that percutaneous transcatheter implantation of pulmonary arterial stent was safe and effective during short and mid-term fol-
low up period. (Korean Circ J 2012;42:40-45)
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tetralogy of Fallot among the various congenital heart defects.
4) 
Uncorrected unilateral stenosis of pulmonary arteries could result in 
decreased perfusion of the affected lung, pulmonary regurgitation, 
or elevation of right ventricular pressure.
5)6) Treatment should be de-
cided by assessing the patient’s hemodynamic status regardless of 
the development of symptoms, because of the increasing risks of 
right ventricular failure, arrhythmia, or sudden death.
7) Improvement 
of right ventricular systolic function was reported in a swine model 
using cardiac magnetic resonance imaging (MRI) after relief of ste-
nosis of the branch pulmonary artery.
8) However, there is limited cli-
nical data for human species mainly due to the relatively small po-
pulation of branch pulmonary artery stenosis patients.
9)
Stent implantation of pulmonary arteries for relief of stenotic le-
sions is still an ‘off-label’ procedure, although it has been a stan-
dardized therapy from the late 1980s.
7) That is not because of ques-
tions concerning its effectiveness and safety, but because of lack of 
interest among government and companies.
10-12) Although few stud-41 Hong Ki Ko, et al.
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ies had demonstrated a high success rate after 20 years of experi-
ence, there has not been any multicenter-randomized controlled 
study.
9)13)14) This study aimed at validating the effectiveness and in-
vestigating complications of pulmonary arterial stent implantation 
in a single institution during midterm follow up period.
15)16)
Subjects and Methods
Between January 1999 and May 2010, patients with unilateral or 
bilateral pulmonary arterial stenosis after corrective surgery for their 
congenital heart defects were enrolled in the Department of Pedi-
atric Cardiology at Asan Medical Center. Only patients who were 
implanted with pulmonary arterial stents were included. A total of 
42 patients (50 stents) were implanted. The ratio of boys to girl was 
0.92. At the time of implantation the patient median age was 12 
years (range 0.5-31 years), and their median weight was 22 kg (ran-
ge 4.8-80.4 kg). Site of lesions were right pulmonary arteries (n=6), 
left pulmonary arteries (n=28), and bilateral pulmonary arteries 
(n=8).
Patient medical records were retrospectively reviewed for demo-
graphic data such as age, weight, and height at intervention. For 
assessing the effectiveness data of catheterization, lung perfusion 
scan, or heart computed tomography (CT) scan and echocardiog-
raphy were also collected before and after the intervention. Insti-
tutional review board of Asan Medical Centre approved this study 
and patient consent was waived.
Catheterization 
Pressure data and diameter of stenotic lesions were obtained 
before and after the implantation. Additionally, the percent steno-
sis (i.e., ratio of diameter at stenotic lesion to that of normal pul-
monary artery at the level of helium) was calculated to compare 
the results. Indications of pulmonary arterial stent implantation 
were when lung perfusion ratio of the normal side to affected side 
was over 2.5 and when the right ventricular systolic pressure was 
over 50% of systemic systolic blood pressure.
Percutaneous transcatheter implantation 
of pulmonary arterial stent
Measurement of the diameter of the stenotic lesion and ipsilateral 
pulmonary artery at the first-branching site helped choose the size 
and length of stent from angiography of pulmonary arteries with 
biplane fluoroscopy. Pre-mounted or hand-mounted stent was pl-
aced accurately at the stenotic lesion and dilated by inflating the 
balloon. In case of a hand-mounted stent, we made a so-called sh-
oulder of balloon to prevent slippage of the stent during catheter 
manipulation.  
Sometimes balloon angioplasty was tried first and the proximal 
part of the stent was widened after implantation, making it easier 
to pass through the stent subsequently. Bilateral stenosis was treat-
ed simultaneously by a double wire technique to minimize displace-
ment of the stent from the optimal site (Figs. 1 and 2). We used vari-
ous type of stents, including Jostent® peripheral (Abbott, Abbott 
Park, IL, USA), Palmaz®
 stent; P**4/8/10B/ 14 series, XD (Johnson & 
Johnson-Cordis, Bridgewater, NJ, USA), Express®
 Vascular LD (Bos-
ton Scientific, Natick, MA, USA), and Wallflex® vascular stent (Bos-
ton Scientific).
Lung perfusion scan
The geometric result of lung perfusion scan before and after im-
plantation was investigated and then the decrement of perfusion 
was calculated by subtracting percent of affected side from that of 
normal value (left : right, 45% : 55%), which was calculated only in 
unilateral pulmonary arterial stenosis. 
Echocardiography and heart CT scan
The non-invasive methods of echocardiography and heart CT scan 
were used to supplementing the results of angiography. 
Statistical analyses
Data was analyzed using Statistical Package for the Social Sci-
ences (SPSS) for Windows, version 12 (SPSS Inc., Chicago, IL, USA). 
Descriptive data for continuous variables are presented as mean± 
SD. Student’s t-test was used for comparing the results before and 
after implantation. Pearson correlation coefficient was used to es-
timate correlation between percent stenosis and perfusion de-
crease. P<0.05 was considered statistically significant.
Results
Demographic data of patients are shown in Table 1. Mean diam-
eter of the narrowest point on pulmonary arterial stenosis was 6.6 
mm and mean percent stenosis was 54%. Patients with tetralogy 
of Fallot with or without pulmonary atresia were most common, 
and consisted of part truncus arteriosus and pulmonary atresia with 
intact ventricular septum in order. 
Validation of effectiveness
The diameter of stenotic lesion after stent implantation increased 
significantly from mean 6.6 mm to mean 12.4 mm and the decre-
ment of perfusion changed significantly from 22.7±8.0% to 10.3± 
9.0% (p<0.001) (Table 2). Changes of each patient in diameter and 
percent stenosis are presented in Fig. 3; an increase in diameter 
from 6.6± 2.1 mm to 12.4±3.6 mm, and drop in percent stenosis from 42  Pediatric Pulmonary Arterial Stent Implantation
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54.1±10.7% to 22.8±12.5% (p<0.001) were evident. Eight patients 
(10 stents) had angiography for suspected re-stenosis on follow-
up study. Period after first intervention was median 4.5 years, age 
was median 15 year-old and weight was median 38.2 kilograms. 
Among the eight patients, only two patients demonstrated re-ste-
nosis to be re-dilated by balloon; the final diameter of these pa-
tients was mean 12.8 mm. Change in percent stenosis was 
22.7±12.4% after the first intervention to 26.8±14.5% at the sec-
ond angiography, indicative of little growth of distal pulmonary 
arteries after stent implantation. 
Assessment of safety
Overall complication rate related to the procedure was 12%. Th-
ere was no mortality, but there were three cases of serious complic-
ations. The first was the perforation of a pulmonary artery to be re-
paired by stent graft in the implanted stent (Fig. 4A). The second was 
a hemothorax during the access to the neck vein for the indwelling 
chest tube. The third was a stent migration to the right ventricle de-
stined for surgical removal and repair due to development of ven-
tricular tachycardia. Other complications included two cases of 
stent displacement re-positioned by transcatheter manipulation. 
One was repositioned by snaring the migrating stent and the other 
case positioned the first-implanted stent at the contralateral pul-
monary artery because of failure to reposition and to implant an-
other stent at the original stenotic lesion. One stent fracture was fo-
und during follow-up, requiring the implantation of another stent in 
the fractured stent (Fig. 4B). Additionally, balloon rupture occurred 
in two cases during inflation.
Discussion
This study showed that short-term result of pulmonary arterial 
stent implantation was effective in increasing the diameter and 
flow of treated pulmonary arteries. Although the long-term result 
Table 1. Patient characteristics
Age at first intervention (years, range) 6.5 0.5-31
Weight at first intervention (kg, range) 21.8 4.8-80.4
Male (n, %) 23 54.8
PA stenosis (n, %)
    Left PA 28 67
    Right PA 6 14
    Both PAs  8 19
Diagnosis (n, %)
   TOF without pulmonary atresia 19 45.2
   TOF with pulmonary atresia 9 21.4
   Truncus arteriosus 3 7.1
   PAIVS 2 4.7
   Others 9 21.4
PA: pulmonary ateries, TOF: tetralogy of Fallot, PAIVS: pulmonary atresia 
with intact ventricular septum
Table 2. Effect of stent implantation
Pre-stent Post-stent p
Minimal PA diameter (mm) 6.6±2.1 12.4±3.60 <0.001
Percent stenosis (%) 54.1±10.7 22.8±12.5 <0.001
Percent of decreased lung perfusion scan results (%) 22.7±8.00 10.3±9.00 <0.001
PA: pulmonary arteries
Fig. 1. Double wire technique in stenosis of both pulmonary arteries. This still frame image shows that two wires were located at both sides of pulmonary 
arteries for simultaneous ballooning of the stents. A: sit-up view. B: lateral view.
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still needs to be clarified, follow-up catheterization showed that rate 
of re-stenosis and percent stenosis remained relatively low after 
intervention. However, dilatation over 14 mm, the normal typical pul-
monary artery size of an adult, is potentially harmful to the vessel when 
using over a 12 Fr sheath for delivering a bulky stent such as the 
Palmaz® genesis stent (Johnson & Johnson-Cordis, Bridgewater, NJ, 
USA).
10)11)15)
Presently, there was no instance of mortality and the rate of com-
Fig. 4. Complications of implantation of pulmonary artery stent. A: after implanting stent vascular leakage was noted (left) then it was repaired by Jos-
tent® Graft Master. After graft implantation within stent, no leakage was found on angiography (right). B: this showed that stent fracture at proximal part 
of stent was found during follow-up catheterization for evaluating re-stenosis of left pulmonary artery.
A   B  
Fig. 3. Changes in diameter of pulmonary arterial stenosis and in percent stenosis. This represents increase of diameter in stenotic lesion and decrease of 
percent stenosis after stent implantation significantly among almost patients.
p<0.001 p<0.053
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Fig. 2. Extra-balloon widening of proximal stent for easy-approach. This image showed ballooning (A) of proximal part of stent after implantation first, 
which made it easier and safer to access distal pulmonary artery next time. Wide opened stent is shown (B).44  Pediatric Pulmonary Arterial Stent Implantation
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plications association with implantation was 12%, similar to the 
long-term reports of other studies.
9)13)14)16)17) One study reported their 
long term result of pulmonary stent experiencing 9.1% of compli-
cation rate (six out of 55 stents) including one death related to 
procedure. The complication rate has decreased with the refine-
ment/ development of equipments and skills.
9)13)14)16) 17) 
After more than 20 years of pediatric stent implantation, this use 
of stents has not received Food and Drug Administration approval, 
which has necessitated the use of peripheral stents intended for 
adult patients (Jostent®, Genesis®, Wallflex®, and Express® stents). 
Additionally, Mega® LD or Maxi® LD stents, which prevent jailing 
vessel, Double stent® LD stent, which increases flexibility, and cus-
tom-built Cheatham-Platinum® (C-P) stent have been used in other 
countries.
18) The maximal diameter of a stent is usually larger than 
recommended in spite of variable shortening in length. For exam-
ple, the maximal diameter of the Express® stent is 12 mm and that 
of the Palmaz genesis® stent is over 20 mm. 
The BIB® stent, which is not available in Korea, consists of an in-
ner and outer balloon. This stent is useful for severe stenotic lesions 
of the large pulmonary artery, a location in which the usual balloon 
cannot resolve the stenosis, necessitating the implantation of a 
butterfly stent. BIB® has a two-step inflation process in which an 
inner small balloon relieves severe stenotic lesion first to avoid 
wrinkling of the stent, which could be a fixed stenosis.
18) 
Since we were unable to reach consensus on indication of stent 
implantation among centers, there are two considerations for the 
procedure: policy for jailed vessel and treatment time for patient 
age and physical condition. Treatment timing is changing to reflect 
device improvements and jailing vessel from stent implantation is 
contraindicated in our institution. Furthermore, accessibility and di-
versity of suitable stents is limited in many center.
19) 
Methods for detecting re-stenosis after stent implantation sh-
ould be effective and safe. This study used a non-invasive method, 
lung perfusion scan, which showed a relationship between perfu-
sion decrease and percent stenosis. However, patients having fol-
low-up catheterization had decreased perfusion ratio but percent 
stenosis was not appreciably increased. This could be postulated to 
be due to the persistent increase of pulmonary resistance or diffuse 
stenosis of distal pulmonary artery without growth after stent im-
plantation. Follow-up modalities used in other studies were mostly 
catheterization, and cardiac MRI. Lung perfusion scan lacks the ab-
ility to detect patency of a jailed vessel. However, we did not perform 
an implant when an adjacent vessel could be jailed if the stent was 
implanted.
This series showed immediate and short-term effectiveness of 
pulmonary arterial stent in congenital heart defects, which had a 
comparable result to surgical correction. However, we were limited 
in validating the result of lung perfusion scan compared to data 
from catheterization because we performed only a limited number 
of cardiac catheterizations. 
We conclude that transcatheter percutaneous implantation of 
pulmonary artery stent is safe and effective during short- and mid-
term follow-up. 
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